Clinical trials underway for 15 new drugs

Published: 2002-05-28 06:59:00

Updated: 2002-05-28 06:59:00

The Korea Food and Drug Administration announced that clinical trials are underway for 15 new drugs by domestic and foreign-invested pharmaceutical firms in Korea. Details:

Product (ingredient)	Company	Current status (indication)
Gemzar (gemcitabine) inj. 200mg, 1g	Lilly Korea	Phase II (non-small-cell lung cancer
Spiriva (tiotropium)	Boehringer Ingelheim ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.